Employees: 01 (2023.0)Legal category: 5485Size: PMECreation date: 2014-05-26 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BOUGLON (47250), Lot-et-Garonne
PHARMACIE DU CLAVIER : revenue, balance sheet and financial ratios
PHARMACIE DU CLAVIER is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BOUGLON (47250),
this company of category PME
shows in 2023 a revenue of 928 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CLAVIER (SIREN 802637850)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
927 537 €
897 784 €
865 662 €
869 683 €
858 911 €
828 203 €
870 379 €
Net income
40 638 €
62 982 €
65 843 €
80 204 €
63 005 €
50 007 €
64 952 €
65 541 €
73 174 €
EBITDA
N/C
N/C
87 615 €
117 786 €
94 760 €
80 034 €
100 644 €
103 571 €
116 816 €
Net margin
N/C
N/C
7.1%
8.9%
7.3%
5.8%
7.6%
7.9%
8.4%
Revenue and income statement
In 2025, PHARMACIE DU CLAVIER generates positive net income of 41 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 73 k€ -> 41 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
40 638 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 32%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
31.782%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
68.303%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU CLAVIER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
283.292
199.014
146.72
115.876
89.537
67.232
47.584
43.174
31.782
Financial autonomy
24.087
30.661
36.639
42.015
47.577
52.87
60.817
63.164
68.303
Repayment capacity
7.804
7.702
7.064
7.659
5.595
4.154
4.134
None
None
Cash flow / Revenue
9.065%
8.825%
8.412%
6.922%
8.52%
9.754%
7.532%
None%
None%
Sector positioning
Debt ratio
31.782025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good
In 2025, the debt ratio of PHARMACIE DU CLAVIER (31.78) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
68.3%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE DU CLAVIER (68.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.13 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE DU CLAVIER (4.13) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 261.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
261.657
Liquidity indicators evolution PHARMACIE DU CLAVIER
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
237.994
256.32
248.704
262.77
269.246
260.112
281.031
290.396
261.657
Interest coverage
9.186
9.407
8.646
9.476
6.881
6.557
3.235
None
None
Sector positioning
Liquidity ratio
261.662025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Excellent
In 2025, the liquidity ratio of PHARMACIE DU CLAVIER (261.66) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
3.23x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE DU CLAVIER (3.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 89 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 795 days. Excellent situation: suppliers finance 706 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
89 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
795 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU CLAVIER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
76 202 €
77 578 €
69 297 €
70 810 €
63 340 €
67 837 €
84 573 €
0 €
0 €
Inventory turnover (days)
25
25
25
26
29
29
29
0
0
Customer payment term (days)
5
6
4
4
3
3
2
73
89
Supplier payment term (days)
33
40
45
39
37
50
43
755
795
Positioning of PHARMACIE DU CLAVIER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU CLAVIER is estimated at
645 539 €
(range 438 066€ - 1 012 940€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
438k€645k€1012k€
645 539 €Range: 438 066€ - 1 012 940€
NAF 5 année 2025
Valuation method used
Net Income Multiple
40 638 €
×
15.9x
=645 539 €
Range: 438 066€ - 1 012 940€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CLAVIER with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CLAVIER
What is the revenue of PHARMACIE DU CLAVIER ?
The revenue of PHARMACIE DU CLAVIER in 2023 is 928 k€.
Is PHARMACIE DU CLAVIER profitable?
Yes, PHARMACIE DU CLAVIER generated a net profit of 41 k€ in 2025.
Where is the headquarters of PHARMACIE DU CLAVIER ?
The headquarters of PHARMACIE DU CLAVIER is located in BOUGLON (47250), in the department Lot-et-Garonne.
Where to find the tax return of PHARMACIE DU CLAVIER ?
The tax return of PHARMACIE DU CLAVIER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CLAVIER operate?
PHARMACIE DU CLAVIER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart